Matinas BioPharma Holdings, Inc. (MTNB) stock
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)
Close on Nov 18, 2026Market cap $13.37MP/E –Yield –
Matinas BioPharma cash
Cash and short-term investments held at the end of each period.
Matinas BioPharma's cash was $761.00K at Jun 30, 2026. For fiscal 2025 it was $4.00M, down 45.1% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $58.68M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.00M | -45.1% |
| FY2024 | Dec 31, 2024 | $7.28M | -47.0% |
| FY2023 | Dec 31, 2023 | $13.76M | -52.2% |
| FY2022 | Dec 31, 2022 | $28.76M | -42.0% |
| FY2021 | Dec 31, 2021 | $49.62M | -15.4% |
| FY2020 | Dec 31, 2020 | $58.68M | +111.3% |
| FY2019 | Dec 31, 2019 | $27.77M | +113.5% |
| FY2018 | Dec 31, 2018 | $13.01M | +78.0% |
| FY2017 | Dec 31, 2017 | $7.31M | +78.0% |
| FY2016 | Dec 31, 2016 | $4.11M | +27.2% |
| FY2015 | Dec 31, 2015 | $3.23M | +24.6% |
| FY2014 | Dec 31, 2014 | $2.59M | -76.1% |
| FY2013 | Dec 31, 2013 | $10.84M | +2454.5% |
| FY2012 | Dec 31, 2012 | $424.36K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $761.00K | -88.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.40M | -65.4% |
| Q4 FY2025 | Dec 31, 2025 | $4.00M | -45.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.44M | -49.7% |
| Q2 FY2025 | Jun 30, 2025 | $6.53M | -54.4% |
| Q1 FY2025 | Mar 31, 2025 | $6.92M | -14.6% |
| Q4 FY2024 | Dec 31, 2024 | $7.28M | -47.0% |
| Q3 FY2024 | Sep 30, 2024 | $10.80M | -40.7% |
| Q2 FY2024 | Jun 30, 2024 | $14.31M | -36.4% |
| Q1 FY2024 | Mar 31, 2024 | $8.11M | -67.4% |
| Q4 FY2023 | Dec 31, 2023 | $13.76M | -52.2% |
| Q3 FY2023 | Sep 30, 2023 | $18.22M | -44.9% |
| Q2 FY2023 | Jun 30, 2023 | $22.51M | -41.5% |
| Q1 FY2023 | Mar 31, 2023 | $24.86M | -43.3% |
| Q4 FY2022 | Dec 31, 2022 | $28.76M | -42.0% |
| Q3 FY2022 | Sep 30, 2022 | $33.05M | -38.6% |
| Q2 FY2022 | Jun 30, 2022 | $38.50M | -35.7% |
| Q1 FY2022 | Mar 31, 2022 | $43.87M | -27.7% |
| Q4 FY2021 | Dec 31, 2021 | $49.62M | -15.4% |
| Q3 FY2021 | Sep 30, 2021 | $53.83M | -14.2% |
| Q2 FY2021 | Jun 30, 2021 | $59.84M | -11.9% |
| Q1 FY2021 | Mar 31, 2021 | $60.67M | -14.8% |
| Q4 FY2020 | Dec 31, 2020 | $58.68M | +111.3% |
| Q3 FY2020 | Sep 30, 2020 | $62.77M | +188678.3% |
| Q2 FY2020 | Jun 30, 2020 | $67.96M | +181522.5% |
| Q1 FY2020 | Mar 31, 2020 | $71.17M | +80.6% |
| Q4 FY2019 | Dec 31, 2019 | $27.77M | +113.5% |
| Q3 FY2019 | Sep 30, 2019 | $33.25K | -99.5% |
| Q2 FY2019 | Jun 30, 2019 | $37.42K | -99.6% |
| Q1 FY2019 | Mar 31, 2019 | $39.41M | +824.5% |
| Q4 FY2018 | Dec 31, 2018 | $13.01M | +78.0% |
| Q3 FY2018 | Sep 30, 2018 | $6.63M | -26.3% |
| Q2 FY2018 | Jun 30, 2018 | $8.90M | -21.0% |
| Q1 FY2018 | Mar 31, 2018 | $4.26M | -73.1% |
| Q4 FY2017 | Dec 31, 2017 | $7.31M | +78.0% |
| Q3 FY2017 | Sep 30, 2017 | $9.00M | +44.7% |
| Q2 FY2017 | Jun 30, 2017 | $11.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.83M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.11M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.22M | – |
See a number that looks wrong?